How CRISPR-Cas9 Edits Specific DNA Sequences

How CRISPR-Cas9 Edits Specific DNA Sequences · 1:07 · Intellect Plus

In short: CRISPR-Cas9 is a programmable gene-editing tool derived from bacterial immune systems that uses a guide RNA and the Cas9 enzyme to precisely modify DNA sequences for treating genetic diseases.

A 1:07 short film in the series “Medicine Breakthroughs”.

Sources used in this film: National Center for Biotechnology Information (NCBI), “Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease”; National Center for Biotechnology Information (NCBI), “CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing”; National Center for Biotechnology Information (NCBI), “The ecology and evolution of microbial CRISPR-Cas adaptive immune systems”; PubMed, “CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing - PubMed”; National Center for Biotechnology Information (NCBI), “Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing”; Nature Structural & Molecular Biology, “Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies - Nature Structural & Molecular Biology”; National Center for Biotechnology Information (NCBI), “Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage”; National Center for Biotechnology Information (NCBI), “Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges”; National Center for Biotechnology Information (NCBI), “CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential”; SAGE Journals, “CRISPR in Medicine: A Systematic Review of Clinical Trials and Therapeutic Applications - Mohammad Rahmanian, Mohadeseh Khoshandam, Marziyeh Mousazadeh, Piao Yang, Hossein Soltaninejad, Pouya Karami Dehkordi, Majid Sadeghizadeh, Mohammad Taghi Hedayati Goudarzi, Amir Hossein Azimi, Mohsen Sheykhhas…”; Yonsei University College of Medicine, “Basic Principles and Clinical Applications of CRISPR-Based Genome Editing”; National Center for Biotechnology Information (NCBI), “A simple validation and screening method for CRISPR/Cas9-mediated gene editing in mouse embryos to facilitate genetically modified mice production”; NIH, “CRISPR in Medicine: A Systematic Review of Clinical Trials and Therapeutic Applications - PubMed”.

Sources used in this film

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/how-crispr-cas9-edits-specific-dna-sequences.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…